Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1401667 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $9.49 · Day +2.71% · Mkt cap $477M · P/E (FY) 15.1× · 1Y +86.4% · Off 52W high −0.2% · Vol (1Y) 60.3% Price2023-08-21 → 2026-08-19 PBYI close: $3.49 on 2023-08-21 to $9.49 on 2026-08-19. Split-adj closes · 240 of 3,599 · price returnⓘ At a glance | Short interest8.0% of sh out | | Days to cover13.9d | | 13F net flow (QoQ)+5.72% | | Top-10 13F concentration56.2% | | Next report (est.)2026-11-05 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | P/E (FY)15.1× | | Sales (TTM)$231.2M | | Earnings (TTM)$26.7M | | ROE28.0% | | Net margin13.6% | | ROIC30.4% | | Debt / equity0.17× | | Total debt / EBITDA0.47× | | Sales growth 3Y0.0% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+59.5% | | 1Y+86.4% | | 3Y+171.9% | | 5Y+39.6% | | 10Y−81.1% | | Since incept. (ann.)−2.7% |
Total return · from 2012-04-24ⓘ Risk | Ann. volatility (1Y)60.3% | | Ann. volatility (3Y)71.0% | | Sharpe (1Y)1.38 | | Sharpe (3Y)0.83 | | Max drawdown (1Y)−25.8% | | Max drawdown (3Y)−69.6% | | Beta (3Y vs SPY)1.81 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| ACORN CAPITAL ADVISORS, LLC | 4.1M | $26M | 8.12% | +0.0% | | BlackRock, Inc. | 3.6M | $23M | 7.07% | −1.2% | | ACADIAN ASSET MANAGEMENT LLC | 2.0M | $13M | 4.01% | +0.8% | | RENAISSANCE TECHNOLOGIES LLC | 1.9M | $12M | 3.82% | −8.5% | | AMERICAN CENTURY COMPANIES INC | 1.9M | $12M | 3.77% | +16.1% | | VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $12M | 3.57% | new | | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.7M | $11M | 3.41% | new | | MILLENNIUM MANAGEMENT LLC | 1.5M | $9M | 2.90% | +8793.2% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-06 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-06 | $0.16 | +33.3% | $56.5M | +7.8% | | 2026-03-31 | 2026-05-07 | −$0.07 | −216.7% | $44.8M | −2.6% | | 2025-12-31 | 2026-02-26 | — | — | $75.5M | +27.7% | | 2025-09-30 | 2025-11-06 | $0.17 | −58.5% | $54.5M | −32.4% |
As-reported XBRL · next 2026-11-05 est.ⓘ Segment mixFY2025 (ended Dec 2025) Product 89% · Royalty 11% product & service · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
